Verve TherapeuticsVERV
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
0
0
(0%)
01/01 08:00 (UTC+8)
Verve TherapeuticsVERV
0
0
(0%)
財務數據
損益表
- 0.01
- 0.01
- 0.02
- 0.03
- 0.05
- 0.06
- 0.07
- 0.07
- 0.13
- 0.33
- 8.93
- 38.74
- 49.07
- 48.92
- 65.03
- 10.71
- 17.51
- 2.59
- 90.53
- 152.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 32,976 | 13,080 | 6,865 | 6,692 | 5,695 | 5,144 | 3,117 | 2,093 | 1,404 | 1,012 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 32,976 | 13,080 | 6,865 | 6,692 | 5,695 | 5,144 | 3,117 | 2,093 | 1,404 | 1,012 |
營業費用 | 69,612 | 69,147 | 63,775 | 65,531 | - | 59,092 | 55,451 | 60,676 | 59,663 | 48,722 |
研發費用 | 54,458 | 55,048 | 49,938 | 50,985 | 48,376 | 46,811 | 43,765 | 47,260 | 47,110 | 37,284 |
推銷及管理費用 | 15,154 | 14,099 | 13,837 | 14,546 | 14,163 | 12,281 | 11,686 | 13,416 | 12,553 | 11,438 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -36,636 | -56,067 | -56,910 | -58,839 | -56,844 | -53,948 | -52,334 | -58,583 | -58,259 | -47,710 |
其他收入及費用 | 223 | 28,557 | -6 | 1,671 | 78 | -713 | 802 | -662 | 738 | 2,177 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -30,954 | -49,962 | -50,029 | -49,739 | -48,630 | -48,320 | -45,691 | -53,807 | -51,975 | -41,032 |
所得稅 | 79 | 73 | 104 | 66 | 106 | 32 | 67 | 176 | - | 53 |
稅後純益 | -31,033 | -50,035 | -50,133 | -49,805 | -48,736 | -48,352 | -45,758 | -53,983 | -51,975 | -41,085 |
基本每股稅後盈餘(元) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.84 | -0.67 |
稀釋每股稅後盈餘(元) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.84 | -0.65 |
基本平均股數(千股) | 88795.00 | 86874.00 | 84632.00 | 84226.00 | 83132.00 | 69671.00 | 63211.00 | 61953.00 | 61787.00 | 61464.00 |
稀釋平均股數(千股) | 88795.00 | 86874.00 | 84632.00 | 84226.00 | 83132.00 | 69671.00 | 63211.00 | 61953.00 | 61787.00 | 61464.00 |
還原基本每股稅後盈餘(元) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.84 | -0.67 |
還原稀釋每股稅後盈餘(元) | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 | -0.69 | -0.72 | -0.87 | -0.84 | -0.65 |
還原基本平均股數(千股) | 88,795 | 86,874 | 84,632 | 84,226 | 83,132 | 69,671 | 63,211 | 61,953 | 61,787 | 61,464 |
還原稀釋平均股數(千股) | 88,795 | 86,874 | 84,632 | 84,226 | 83,132 | 69,671 | 63,211 | 61,953 | 61,787 | 61,464 |
EBITDA(千元) | -31,131 | -50,417 | -51,020 | -51,610 | -50,965 | -50,141 | -47,710 | -56,166 | -54,703 | -42,248 |